Pfizer: all 4,072 studies
Page 38 of 41. Open to participants first (153), then studies with results posted, then the rest; newest registration first within each.
- Study Evaluating Effexor XR in Elderly Patients With Major Depression.CompletedNCT00225485Phase 3
- Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid TumorsCompletedNCT00225121Phase 1
- Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder SyndromeCompletedNCT00220402Phase 3
- Two Phase Extension Trial of SP668 to Investigate the Safety and Tolerability of Sustained Release Fesoterodine in Subjects With Overactive Bladder: a Double-Blind Phase Followed by an Open-Label Extension PhaseCompletedNCT00220389Phase 2
- Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder SyndromeCompletedNCT00220376Phase 3
- A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder SyndromeCompletedNCT00220363Phase 3
- Assessment Of Efficacy and Safety UK-390,957 In Men With Premature EjaculationCompletedNCT00219635Phase 2/3
- A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00219622Phase 2
- Assessment Of Safety Of UK-390,957CompletedNCT00219609Phase 2/3
- Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature EjaculationCompletedNCT00219583Phase 2/3
- Dalacin-T Gel Post Approval StudyCompletedNCT00219570Phase 4
- A Safety and Efficacy Study of Dexmedetomidine in ICU Patients Requiring Continuous SedationCompletedNCT00216190Phase 4
- Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens.CompletedNCT00205816Phase 3
- Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis MediaCompletedNCT00195611
- Study Comparing Venlafaxine vs. Paroxetine in Panic DisorderCompletedNCT00195598Phase 3
- Study Evaluating Isovorin in Colon CancerCompletedNCT00195585Phase 3
- Study Evaluating Isovorin in Advanced/Recurrent Gastric CancerCompletedNCT00195572Phase 3
- Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric DisorderCompletedNCT00195559Phase 3
- Study Evaluating DVS-233 SR for Treatment of Vasomotor Symptoms Associated With MenopauseCompletedNCT00195546Phase 3
- Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic PatientsCompletedNCT00195533
- Study Evaluating Totelle® in Menopausal Symptoms and Sexual FunctionCompletedNCT00195520Phase 4
- Study Evaluating Sirolimus in Kidney Transplant Recipients in IndiaCompletedNCT00195481Phase 4
- Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking SirolimusCompletedNCT00195468Phase 4
- Study Evaluating Estradiol/Trimegestone in Vasomotor Symptoms (VMS) in Post-Menopausal Women.CompletedNCT00195455Phase 4
- Study Investigating Enbrel Treatment for Ankylosing SpondylitisCompletedNCT00195416
- Study Investigating Administration of Prevenar for Post-Marketing SurveillanceCompletedNCT00195390
- Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in SpainCompletedNCT00195377
- Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in SpainCompletedNCT00195364
- Study Evaluating TTI-237 in Advanced Malignant Solid Tumors.TerminatedNCT00195325Phase 1
- Study Evaluating Vaccine in Adults With HIVTerminatedNCT00195312Phase 1
- Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & NeckCompletedNCT00195299
- Study Evaluating Piperacillin/Tazobactam in Complicated Urinary Infections.CompletedNCT00195286
- Study Evaluating TTI-237 in Advanced Malignant Solid TumorsTerminatedNCT00195247Phase 1
- Study Evaluating Vaccine in Adults With HIVCompletedNCT00195234Phase 1
- Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia BCompletedNCT00195221
- Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive EsophagitisCompletedNCT00195208Phase 3
- Study Evaluating Rapamune in Transplant Recipients in the Nordic CountriesCompletedNCT00195195
- Use of 852A in Metastatic Cutaneous Melanoma.CompletedNCT00189332Phase 2
- Donepezil in the Prevention of Post-Operative Cognitive DeclineCompletedNCT00182845Phase 4
- A Methodological Open Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarization and QT Interval At Fixed Heart Rate Under Autonomic BlockadeCompletedNCT00174512Phase 1
- Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile DysfunctionCompletedNCT00174486Phase 2
- A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in ChildrenCompletedNCT00174473Phase 1/2
- Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast CancerCompletedNCT00174434Phase 1
- Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final HeightCompletedNCT00174421Phase 3
- Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational AgeCompletedNCT00174408Phase 3
- MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung CancerTerminatedNCT00174369Phase 2
- PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC PatientsCompletedNCT00174356Phase 1
- Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer PatientsCompletedNCT00174343Phase 2
- Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The HipCompletedNCT00174317Phase 4
- Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature SecondaryCompletedNCT00174278Phase 3
- Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.TerminatedNCT00174239Phase 4
- Treatment of Adult ADHD With Atomoxetine or Atomoxetine and BusparCompletedNCT00174226Phase 2
- Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With RisperidoneCompletedNCT00174200Not applicable
- Study Comparing Blood Levels of ReFacto and Advante in Hemophilia AWithdrawnNCT00168051Phase 4
- Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology UnitsCompletedNCT00167999
- Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive CareCompletedNCT00167986
- Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual UseCompletedNCT00167973
- Study Evaluating Vancomycin-Resistant Enterococci in a Hematology UnitCompletedNCT00167960
- Study Evaluating Sirolimus in Kidney Transplant Recipients.CompletedNCT00167947Phase 3
- Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic VaginitisCompletedNCT00167921Phase 1
- Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in ChildrenCompletedNCT00163618
- Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)CompletedNCT00163540Phase 4
- A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.CompletedNCT00163111Phase 3
- A Study of UK-369,003 on the Safety and Efficacy in Patients With COPDCompletedNCT00163098Phase 1/2
- The Effects of an NR2B NMDA Antagonist, CP-101,606, in Patients With Parkinson's DiseaseCompletedNCT00163085Phase 2
- The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With MDDCompletedNCT00163059Phase 2
- TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)CompletedNCT00161967Phase 4
- Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 YearsCompletedNCT00161954Phase 4
- Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216CompletedNCT00161941
- Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy InfantsCompletedNCT00161928Phase 3
- FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 YearsCompletedNCT00161889Phase 2
- FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 YearsCompletedNCT00161876Phase 3
- Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 YearsCompletedNCT00161863Phase 3
- FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 YearsCompletedNCT00161850Phase 2
- Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPURCompletedNCT00161824Phase 3
- Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.CompletedNCT00161798Phase 2
- Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 YearsCompletedNCT00161785Phase 4
- Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.CompletedNCT00161772Phase 2
- Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 YearsCompletedNCT00161746Phase 2/3
- Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMSCompletedNCT00161681Phase 3
- Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual CareCompletedNCT00161668
- Study Evaluating Etanercept and Methotrexate in Plaque PsoriasisCompletedNCT00161655Phase 4
- Study Evaluating CMD-193 in Advanced Malignant Solid TumorsCompletedNCT00161642Phase 1
- Study Evaluating rhBMP-2/CPM in Closed Distal Radius FracturesCompletedNCT00161629Phase 1
- Effect Of A Treatment Optimization Program To Improve Satisfaction With ViagraCompletedNCT00159848Phase 4
- Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHDCompletedNCT00159835Phase 4
- Placebo Controlled Dose-Response Study Of PD-217,014 In The Treatment Of Postherpetic NeuralgiaTerminatedNCT00159640Phase 2
- Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient AdolescentsCompletedNCT00156143Phase 3
- Canadian Pegvisomant Compassionate Study In Acromegalic PatientsCompletedNCT00151437Phase 4
- Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)CompletedNCT00151398Phase 2
- Study Evaluating Inhibitor Specificity in Hemophilia AWithdrawnNCT00151385Phase 4
- Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)CompletedNCT00151333Phase 2
- Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.CompletedNCT00150449Phase 3
- To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia.CompletedNCT00150436Phase 3
- To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.CompletedNCT00150423Phase 3
- Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling GlucoseCompletedNCT00150410Phase 3
- A Study of the Safety and Efficacy of Tofimilast in Adult AsthmaticsCompletedNCT00150397Phase 2
- Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in JapanCompletedNCT00150332Phase 3
- An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With VfendTerminatedNCT00150319Phase 1/2
- Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.CompletedNCT00150293Phase 3